capivasertib,fulvestrant 
astrazeneca,otsuka
['bcsm', 'mbc', 'capivasertib', 'biomarker']
faktion update: capivasertib+ fulvestrant post ai in hr+her2- mbc capivasertib + fulv extends survival (pfs and os) expanded biomarker testing suggests that benefit only seen within pi3k/akt/pten pathway-altered tumors cdk4/6i naive population #asco22 #bcsm 
Breast Medical Oncologist @UNC_Lineberger Prior @JCO_ASCO editorial fellow. Views are my own.